“It is with great regret and sadness we announce this very tragic and unexpected information,” says the Board of Directors, Karo Pharma. “Anders Lönner has suddenly and unexpected passed away. Our thoughts go to his family and those closest to him.”
Anders Lönner joined Karo Pharma as Executive Chairman of the Board in 2014. He has influenced the pharmaceutical industry in Sweden in an extraordinary way, states the company. This is evident from all the special acknowledgements that Anders has received throughout the years.
He started his career at Astra Pharmaceuticals, Managing Director at Astra Läkemedel where after he was the CEO of Meda for many years. With Anders leadership and through the business model that he implemented Meda developed exceptionally. The company went from being a small agency company to an international pharmaceutical company, continues Karo Pharma in their press release.
“Anders has in his role as Executive Chairman of the Board driven a successful transformation of Karo Pharma AB from an unprofitable research company to a profitable specialty pharma company. Anders integrity, empathy and creative mindset has made him a very successful businessman and entrepreneur within the pharmaceutical industry.”
Anders was elected Honorary Doctor of Medicine at Karolinska Institutet. The motivation was; “Anders Lönner has during many years shown strong commitment for Karolinska Institutet, particularly within the area of clinical development”
The Board Member, Håkan Åström, will now assume the role as Acting Chairman of the Board.
